摘要
病毒的直接损伤及免疫机制共同参与了病毒性心肌炎的致病。在病毒诱发的炎症至自身免疫的产生及进展过程中细胞因子发挥了重要作用。
出处
《汕头大学医学院学报》
2002年第4期246-248,共3页
Journal of Shantou University Medical College
参考文献16
-
1Yoshinori S,Naoyuki T,Hideo Y et al.Expression of cytokine mRNA in murine hearts with acute myocarditis caused by coxsackievirus B3[J].Journal Of Pathology,1997,183:105-108
-
2Andreas H,Carsten M,Hans S et al. Coxsackie virus B3-induced production of tumor necrosis factor-α, IL-1β and IL-6 in human monocytes[J].The Journal Of Immunology,1992,148:2270-2275
-
3Testsuo S,Akira M,Shigetake S.Persistent expression of cytikine in the chronic stage of viral myocarditis in mice[J].Circulation,1996,94:2930-2937
-
4Kishimoto C,Kuroki Y,Hiraoka Y et al.Cytokine and murine coxsackie myocarditis:interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage[J].Circulation,1994,89:2836-2842
-
5Gerhard G,Christian LP,Ivan H et al.Induction of autoimmune myocarditis in interleukin-2-deficient mice[J].Circulation,1997,95:1773-1776
-
6Fiorentino DF,Bond MW,Mosmann TR.Two types of mouse Thelper cell:Th2 clones secrete a factor that inhibits cytokine production by Th1 clones[J].J Excep Med,1989,170:2081-2095
-
7Ryosuke N,Akira M,Testsuo S et al.Treatment of experimental viral myocarditis with interleukin-10[J].Circulation,1999,100:1102-1108
-
8Siegener MS,Heim A,Figulla HR.Subclassification of dila- ted cardiomyopathy and interferon treatment[J].Eur Heart J,1995,16(Suppl O):147-149
-
9Miric M,Miskovic A,Vasiljevic JD et al.Interferon and thymic homones in the therapy of human myocarditis and idiopathic dilated cardiomyopathy[J].Eur Heart J,1995,16(Suppl O):150-152
-
10Norimi Y,Masafumi S,Motohiro O et al.Effect of intranasal administration of recombinant murine interferon-γ on murine acute myocarditis caused by encephalomyocarditis virus[J].Circulation,1998,97:1017-1023
同被引文献11
-
1Rezkalla S,Kloner R N,Khatib G,et al.Effect of metoprolol on the acute phase of Coxsackievirus B3 murine myocarditis[J].J Am Coil Cardiol,1988,12(8):412-414.
-
2Matsumori A,Sasayama S.The role of infammatory mediators in the failing heart:Immunomodulation of cytokines in experimental models of heart failure[J].Heart Fail Rev,2001,6(2):129-136.
-
3Fuse K,Kodama M,Okura Y,et al.Short-term prognostic value of initial serum levels of interleukin-10 in patients with acute myocarditis[J].Eur J Heart Fail,2005,7(1):109-112.
-
4Hofmann P,Schmidtke M,Stelzner A,et al.Suppression of proinflammatory cytokines and induction of lL-10 in human monocytes after coxsackievirus B3 infection[J].Med Virol,2001,64(4):487-498.
-
5Huber S. T cells in coxsackievirus - induced myocarditis[ J ]. Viral Immunol, 2004, 17(2) : 152-164.
-
6Wu CY, Feng Y, Qian GC, et al. α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myo- carditis[Jl. Clin Exp Immunol, 2010, 162(1 ) :178-157.
-
7Seko Y, Kayagaki N, Seino K, et al. Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3 [ J] J Am Coil Cardiol, 2002, 39 (8) : 1 399-1 403.
-
8Poffenberger MC, Straka N, El Warty N, et al. Lack of IL-6 during coxsackievirus infection heightens the early immune response resuhing in increased severity of chronic autoimmune myocarditis [J]. PLoS One, 2009, 4(7):6 207.
-
9吴铁吉.病毒性心肌炎诊断标准(修订草案)[J].中国实用儿科杂志,2000,15(5):315-315.
-
10杨英珍,熊丁丁.病毒性心肌炎治疗现状[J].中国新药与临床杂志,1998,17(5):307-309. 被引量:44
引证文献3
-
1莫云芝.小儿病毒性心肌炎血清IL-6和IFN-γ水平的检测及其意义[J].河南职工医学院学报,2011,23(3):299-300. 被引量:2
-
2张佩,黄星原,徐木珍.IL-10对CVB3病毒性心肌炎治疗作用的研究[J].中国妇幼健康研究,2011,22(5):576-578. 被引量:2
-
3吴凡,邱汉婴,董继华,廖玉华.黄芪对病毒性心肌炎心脏细胞因子mRNA表达的影响[J].临床心血管病杂志,2004,20(3):165-168. 被引量:38
二级引证文献42
-
1闻飞飞,王中男.中药治疗柯萨奇B_3病毒性心肌炎研究概况[J].长春中医学院学报,2004,20(4):61-62.
-
2方祝元.病毒性心肌炎中西医结合治疗进展[J].江苏中医药,2005,26(3):56-59. 被引量:2
-
3向平,易岂建.病毒性心肌炎发病机理及黄芪免疫干预作用研究进展[J].儿科药学杂志,2005,11(3):10-12. 被引量:8
-
4阳艳,黄大为.黄芪联合维生素C注射液治疗病毒性心肌炎118例临床观察[J].合肥医学院学报,2005,28(4):371-372. 被引量:1
-
5王莹威.中医药治疗病毒性心肌炎的研究进展[J].中医药信息,2006,23(2):13-14. 被引量:3
-
6刘保红,陈蓉,王佑华.中医药治疗病毒性心肌炎分子遗传学机制研究进展[J].中国分子心脏病学杂志,2005,5(5):733-737.
-
7黄伟雄,黄春南,程曼.急性重症病毒性心肌炎26例临床分析[J].实用心脑肺血管病杂志,2006,14(4):293-293. 被引量:2
-
8甄莉,吴媛.黄芪注射液对银屑病外周血淋巴细胞白介素-2及其受体的影响[J].中国中西医结合皮肤性病学杂志,2006,5(2):63-65. 被引量:7
-
9朱红俊,陆佳.黄芪治疗病毒性心肌炎药理研究进展[J].中国中医急症,2007,16(1):95-96. 被引量:35
-
10吴克明,陈义林.急性重症病毒性心肌炎临床分析[J].中国心血管病研究,2007,5(3):182-184. 被引量:14
-
1邓荷萍,王朝晖.巨细胞病毒在动脉粥样硬化中的作用[J].临床心血管病杂志,2001,17(1):43-45. 被引量:8
-
2吴文涛,储旭华,候熙德.柯萨奇病毒诱发实验性多发性肌炎的初步研究[J].卒中与神经疾病,1996,3(4):176-178. 被引量:5
-
3柳英丽,张宛夏,孙巧玲.孟鲁司特钠治疗病毒诱发儿童哮喘56例疗效观察[J].中国中西医结合儿科学,2013,5(2):129-130. 被引量:9
-
4潘理会,李春辉.柯萨奇B3病毒诱发小鼠心肌炎的动态研究[J].山东医药,2007,47(28):28-29. 被引量:2
-
5刘国荣,申昆玲.病毒诱发的喘息和哮喘的免疫学机制[J].国外医学(儿科学分册),2001,28(2):91-93. 被引量:47
-
6张晓英.乙型肝炎病毒相关性肾炎[J].中华保健医学杂志,2009,11(3):247-249. 被引量:4
-
7Schu.,V,张超.EB病毒诱发的淋巴细胞增生性疾病[J].德国医学,1993,10(1):19-20.
-
8郑吉善.5岁以下儿童哮喘116例临床特征分析[J].实用医学杂志,2006,22(1):61-63. 被引量:4
-
9董苗英,沈芝仙,王美娟.拉米夫定治疗乙型肝炎病毒诱发YMDD变异的护理[J].护理与康复,2009,8(5):448-449. 被引量:1
-
10朱晔,王孟清,罗银河,陈锡军,刘克丽,莫非钧,舒兰.咳喘宁治疗呼吸道病毒感染诱发小儿哮喘临床疗效与相关因素分析[J].中国中医药信息杂志,2007,14(2):63-64. 被引量:3